Paweł Borowiecki

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Alcohol Consumption

Structure Activity Relationship

Top Venues

International journal of molecular sciences

Communications chemistry

The Journal of organic chemistry

Chembiochem : a European journal of chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Beata Zdun, Paweł Borowiecki
Vinyl 3-(Dimethylamino)propanoate as an Irreversible Acyl Donor Reagent in a Chromatography-free Lipase-Catalyzed Kinetic Resolution of sec-Alcohols. Chembiochem : a European journal of chemical biology (2024)
Beata Zdun, Tamara Reiter, Wolfgang Kroutil, Paweł Borowiecki
Chemoenzymatic Synthesis of Tenofovir. The Journal of organic chemistry (2023)
Patrycja Wińska, Monika Wielechowska, Mirosława Koronkiewicz, Paweł Borowiecki
Synthesis and Anticancer Activity of Novel Dual Inhibitors of Human Protein Kinases CK2 and PIM-1. Pharmaceutics 15 (7) (2023)
Aleksandra Rudzka, Beata Zdun, Natalia Antos, Lia Martínez Montero, Tamara Reiter, Wolfgang Kroutil, Paweł Borowiecki
Biocatalytic characterization of an alcohol dehydrogenase variant deduced from Lactobacillus kefir in asymmetric hydrogen transfer. Communications chemistry 6 (1) (2023)
Paweł Borowiecki, Beata Zdun, Natalia Popow, Magdalena Wiklińska, Tamara Reiter, Wolfgang Kroutil
Development of a novel chemoenzymatic route to enantiomerically enriched β-adrenolytic agents. A case study toward propranolol, alprenolol, pindolol, carazolol, moprolol, and metoprolol. RSC advances 12 (34) (2022)
Paweł Borowiecki
Chemoenzymatic Synthesis of Optically Active Ethereal Analog of iso -Moramide-A Novel Potentially Powerful Analgesic †. International journal of molecular sciences 23 (19) (2022)
Konrad Chojnacki, Patrycja Wińska, Olena Karatsai, Mirosława Koronkiewicz, Małgorzata Milner-Krawczyk, Monika Wielechowska, Maria Jolanta Rędowicz, Maria Bretner, Paweł Borowiecki
Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-1-ols-Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties. International journal of molecular sciences 22 (12) (2021)